Add BrightSurf on Google Email

Science News for April 10, 2021


New CAR T approach minimizes resistance, helps avoid relapse in non-Hodgkin's B-cell lymphoma

Researchers have developed a new chimeric antigen receptor (CAR) T cell immunotherapy that targets both CD19 and CD20 proteins, achieving complete metabolic responses in four out of five patients with relapsed or refractory B-cell lymphoma. The approach minimizes treatment resistance and prevents relapse by recognizing multiple targets.

Auxin visualized for the first time

The new biosensor, AuxSen, enables scientists to observe spatial and temporal redistribution dynamics of auxin in plants, revealing rapid uptake and slower export. It also shows rapid auxin redistribution after root tip rotation, a response not previously measurable.

SourceMax-Planck-Gesellschaft·JournalNature·DateApr 10, 2021